Home > Balance Sheet > NEULAND LABORATORIES

NEULAND LABORATORIES
Contingent Liabilities

    Back to Balance Sheet
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹8.97 Cr₹28 Cr₹91 Cr₹75 Cr₹105 Cr

What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?

The latest Contingent Liabilities ratio of NEULAND LABORATORIES is ₹8.97 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹8.97 Cr
Mar2024₹28 Cr
Mar2023₹91 Cr
Mar2022₹75 Cr
Mar2021₹105 Cr

How is Contingent Liabilities of NEULAND LABORATORIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹8.97 Cr
-67.65
Mar2024 ₹28 Cr
-69.60
Mar2023 ₹91 Cr
22.14
Mar2022 ₹75 Cr
-28.68
Mar2021 ₹105 Cr -

Compare Contingent Liabilities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹19,134.7 Cr 13% 18.5% 22.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

13%

18.5%

22.4%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses